Hsbc Holdings PLC Ironwood Pharmaceuticals Inc Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 11,058 shares of IRWD stock, worth $38,260. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,058

Previous 25,923 57.34%

Holding current value

$38,260

Previous $169,000 73.37%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.93 - $7.04 $58,419 - $104,649	-14,865 Reduced 57.34%	11,058 $45,000
Q2 2024 Aug 12, 2024	BUY	$5.58 - $8.61 $54,349 - $83,861	9,740 Added 60.19%	25,923 $169,000
Q1 2024 May 15, 2024	SELL	$8.32 - $15.45 $112,103 - $208,173	-13,474 Reduced 45.43%	16,183 $140,000
Q4 2023 Feb 12, 2024	SELL	$8.79 - $11.51 $2 Million - $2.61 Million	-227,144 Reduced 88.45%	29,657 $339,000
Q3 2023 Nov 13, 2023	BUY	$8.25 - $11.35 $84,925 - $116,836	10,294 Added 4.18%	256,801 $2.47 Million
Q2 2023 Aug 11, 2023	SELL	$10.1 - $11.6 $36,865 - $42,340	-3,650 Reduced 1.46%	246,507 $2.62 Million
Q1 2023 May 15, 2023	BUY	$10.37 - $12.56 $1.12 Million - $1.36 Million	108,020 Added 76.0%	250,157 $2.63 Million
Q4 2022 Feb 14, 2023	BUY	$9.9 - $12.43 $752,023 - $944,207	75,962 Added 114.79%	142,137 $1.76 Million
Q3 2022 Nov 14, 2022	SELL	$10.14 - $12.38 $483,110 - $589,832	-47,644 Reduced 41.86%	66,175 $692,000
Q2 2022 Aug 11, 2022	BUY	$11.05 - $12.72 $1.01 Million - $1.16 Million	91,019 Added 399.21%	113,819 $1.31 Million
Q1 2022 May 16, 2022	SELL	$10.61 - $12.88 $245,451 - $297,965	-23,134 Reduced 50.36%	22,800 $286,000
Q4 2021 Feb 11, 2022	BUY	$10.86 - $13.95 $30,592 - $39,297	2,817 Added 6.53%	45,934 $535,000
Q3 2021 Nov 12, 2021	SELL	$11.92 - $13.92 $136,245 - $159,105	-11,430 Reduced 20.95%	43,117 $566,000
Q2 2021 Aug 13, 2021	BUY	$10.16 - $13.11 $288,523 - $372,297	28,398 Added 108.6%	54,547 $702,000
Q1 2021 May 14, 2021	SELL	$9.04 - $11.86 $55,026 - $72,191	-6,087 Reduced 18.88%	26,149 $292,000
Q4 2020 Feb 12, 2021	BUY	$9.05 - $12.2 $145,668 - $196,371	16,096 Added 99.73%	32,236 $367,000
Q3 2020 Nov 12, 2020	SELL	$8.99 - $10.74 $211,345 - $252,486	-23,509 Reduced 59.29%	16,140 $146,000
Q2 2020 Aug 14, 2020	BUY	$9.14 - $11.97 $362,391 - $474,598	39,649 New	39,649 $409,000
Q1 2020 May 15, 2020	SELL	$8.58 - $14.01 $434,353 - $709,242	-50,624 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$8.22 - $14.0 $188,805 - $321,566	-22,969 Reduced 31.21%	50,624 $675,000
Q3 2019 Nov 14, 2019	BUY	$8.59 - $10.96 $632,163 - $806,579	73,593 New	73,593 $632,000

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $530M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Ironwood Pharmaceuticals Inc Transaction History